dr joseph harding dihexa ADDF Speaker – JR Harding

The trial compared treatment to placebo only, not to established hair loss treatments

10.1016/j.jpeds.2010.10.012 75

A phase 3 trial called REDEFINE-1 included over 3,400 people who were overweight or obese with one or more comorbidities (like hypertension or cardiovascular disease), but not type 2 diabetes

Since they are bioidentical, there are no side effects

Every person metabolic context is unique, and lab values must be interpreted within the full clinical picture

However, as with any skincare or health product, its crucial to exercise caution, perform patch tests, and follow recommended dosages to ensure safe and effective use